AXSMAxsome Therapeutics, Inc.
$145.02+16% 1Y
$145.02
$127.0652 weeks$255.17
Is the price fair?
What AXSM's price assumes
Axsome Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 9.78× revenue.
9.78
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 91.2
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 9.61
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 91.2
- EV / EBIToperating margin −24%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 9.61
- Market capitalisation52.4 million shares, counted Aug 3, 2026
- $7.60B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.